Suppr超能文献

尿调节蛋白:不仅仅是慢性肾脏病进展的标志物。

Uromodulin: more than a marker for chronic kidney disease progression.

作者信息

LaFavers Kaice, Garimella Pranav S

机构信息

Division of Nephrology and Hypertension, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.

Division of Nephrology and Hypertension, University of California San Diego, San Diego, California, USA.

出版信息

Curr Opin Nephrol Hypertens. 2023 May 1;32(3):271-277. doi: 10.1097/MNH.0000000000000885. Epub 2023 Mar 9.

Abstract

PURPOSE OF REVIEW

Uromodulin, a protein that is highly conserved across several species through evolution, functions to maintain homeostasis and prevent disease development and progression. Historically, the role of uromodulin has been thought to be limited to the kidney and genitourinary tract. This review highlights developments indicating a broader role of uromodulin in human health.

RECENT FINDINGS

Although initially discovered in the urine and found to have immunomodulatory properties, recent findings indicate that serum uromodulin (sUMOD) is distinct from urine uromodulin (uUMOD) in its structure, function, and regulation. uUMOD binds pathogenic bacteria in the urine preventing infection and is also upregulated in kidneys undergoing repair after injury. Uromodulin knockout mice exhibit higher mortality in the setting of sepsis which is also associated with upregulation of sUMOD. sUMOD lowers calcification risk but this may be influenced by presence of kidney disease.

SUMMARY

Uromodulin is an evolutionarily conserved protein produced exclusively in the kidney tubule cells with evolving roles being reported both in the kidney and systemically. Further research should be focused at harnessing its use as a potential therapeutic.

摘要

综述目的

尿调节蛋白是一种在进化过程中在多个物种间高度保守的蛋白质,其功能是维持体内平衡并预防疾病的发生和发展。历史上,尿调节蛋白的作用一直被认为局限于肾脏和泌尿生殖道。本综述重点介绍了表明尿调节蛋白在人类健康中具有更广泛作用的研究进展。

最新发现

尽管尿调节蛋白最初是在尿液中发现并被认为具有免疫调节特性,但最近的研究结果表明,血清尿调节蛋白(sUMOD)在结构、功能和调节方面与尿液尿调节蛋白(uUMOD)不同。uUMOD在尿液中结合致病细菌以预防感染,并且在损伤后正在修复的肾脏中也会上调。尿调节蛋白基因敲除小鼠在脓毒症情况下死亡率更高,这也与sUMOD的上调有关。sUMOD降低钙化风险,但这可能受肾脏疾病的影响。

总结

尿调节蛋白是一种仅在肾小管细胞中产生的进化保守蛋白,其在肾脏和全身的作用都在不断演变。进一步的研究应聚焦于将其用作潜在治疗手段。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验